Matsuda N - Search Results

1

Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.

Sato K, Miyakawa M, Eto M, Inaba T, Matsuda N, Shiga T, Ohnishi S, Kasanuki H. Sato K, et al. Among authors: matsuda n. Endocr J. 1999 Jun;46(3):443-51. doi: 10.1507/endocrj.46.443. Endocr J. 1999. PMID: 10503998 Free article.

2

Mild and short recurrence of type II amiodarone-induced thyrotoxicosis in three patients receiving amiodarone continuously for more than 10 years.

Sato K, Shiga T, Matsuda N, Onoda N, Takano K, Hagiwara N, Kasanuki H. Sato K, et al. Among authors: matsuda n. Endocr J. 2006 Aug;53(4):531-8. doi: 10.1507/endocrj.k06-027. Epub 2006 Jul 10. Endocr J. 2006. PMID: 16829703 Free article.

3

Amiodarone-Induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan.

Shiga T, Wakaumi M, Matsuda N, Shoda M, Hagiwara N, Sato K, Kasanuki H. Shiga T, et al. Among authors: matsuda n. Jpn Circ J. 2001 Nov;65(11):958-60. doi: 10.1253/jcj.65.958. Jpn Circ J. 2001. PMID: 11716246 Free article.

4

Effect of low-dose amiodarone on atrial fibrillation or flutter in Japanese patients with heart failure.

Shiga T, Wakaumi M, Imai T, Suzuki T, Hosaka F, Yamada Y, Matsuda N, Shoda M, Sugiura R, Hagiwara N, Kasanuki H. Shiga T, et al. Among authors: matsuda n. Circ J. 2002 Jun;66(6):600-4. doi: 10.1253/circj.66.600. Circ J. 2002. PMID: 12074281 Free article.

5

Amiodarone distribution in human tissues after long-term therapy: a case of arrhythmogenic right ventricular cardiomyopathy.

Hosaka F, Shiga T, Sakomura Y, Wakaumi M, Matsuda N, Kasanuki H. Hosaka F, et al. Among authors: matsuda n. Heart Vessels. 2002 May;16(4):154-6. doi: 10.1007/s003800200012. Heart Vessels. 2002. PMID: 12224786

6

Hemodynamics during chronic amiodarone administration in Japanese patients with idiopathic dilated cardiomyopathy and ventricular arrhythmia: a retrospective study.

Suzuki T, Shiga T, Wakaumi M, Matsuda N, Ishizuka N, Kasanuki H. Suzuki T, et al. Among authors: matsuda n. J Cardiol. 2003 Apr;41(4):169-73. J Cardiol. 2003. PMID: 12728537

7

Amiodarone decreases plasma brain natriuretic peptide level in patients with heart failure and ventricular tachyarrhythmia.

Shiga T, Hosaka F, Wakaumi M, Matsuda N, Tanizaki K, Kajimoto K, Shoda M, Hagiwara N, Kasanuki H. Shiga T, et al. Among authors: matsuda n. Cardiovasc Drugs Ther. 2003 Jul;17(4):325-33. doi: 10.1023/a:1027343606509. Cardiovasc Drugs Ther. 2003. PMID: 14618094 Clinical Trial.

8

Incidence and predictors of pulmonary toxicity in Japanese patients receiving low-dose amiodarone.

Yamada Y, Shiga T, Matsuda N, Hagiwara N, Kasanuki H. Yamada Y, et al. Among authors: matsuda n. Circ J. 2007 Oct;71(10):1610-6. doi: 10.1253/circj.71.1610. Circ J. 2007. PMID: 17895560 Free article.

9

Reverse use-dependent QT prolongation during infusion of nifekalant in a case of recurrent ventricular tachycardia with old myocardial infarction.

Shiga T, Ando S, Suzuki T, Matsuda N, Kasanuki H. Shiga T, et al. Among authors: matsuda n. J Electrocardiol. 2001 Jan;34(1):77-80. doi: 10.1054/jelc.2001.22063. J Electrocardiol. 2001. PMID: 11239376

10

Antiarrhythmic effect of nifekalant on atrial tachyarrhythmia in four patients with severe heart failure.

Shiga T, Matsuda N, Fuda Y, Haruta S, Hagiwara N, Kasanuki H. Shiga T, et al. Among authors: matsuda n. J Cardiol. 2002 Mar;39(3):159-64. J Cardiol. 2002. PMID: 11912950

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

932 results

Search Page

Filters